Next Article in Journal
Idiopathic Pulmonary Fibrosis Coexisting with Lung Cancer
Previous Article in Journal
Development of Bronchiectasis during Long-Term Rituximab Treatment for Rheumatoid Arthritis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 86
Issue 6
10.5603/ARM.a2018.0051
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Epicardial Fat in Patients with Chronic Obstructive Pulmonary Disease as a Marker of High Cardiovascular Risk

by
Milan Sova
1,
Samuel Genzor
1,*,
Vítězslav Kolek
1,
Filip Čtvrtlík
2,
Amjad Ghazal Asswad
3,
Ondřej Zela
4 and
Zdeněk Tauber
5
1
Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
2
Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
3
Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
4
Department of Internal Diseases, Hospital Frydek-Mistek, Frydek-Mistek, Czech Republic
5
Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2018, 86(6), 314-318; https://doi.org/10.5603/ARM.a2018.0051
Submission received: 12 December 2018 / Revised: 17 December 2018 / Accepted: 17 December 2018 / Published: 30 December 2018

Abstract

Chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVD) are commonly interconnected, and this coincidence negatively influences patients’ mortality and morbidity. On the basis of the current available data originating mainly from cardiovascular studies epicardial fat (EF) has been proposed as a marker of cardiovascular risk. This review is focused on a potential role of epicardial fat as a new biomarker for risk stratification of COPD patients. Epicardial fat may present an important link between chronic obstructive pulmonary disease and cardiovascular diseases, mainly coronary artery disease.
Keywords: epicardial fat; COPD; risk stratification epicardial fat; COPD; risk stratification

Share and Cite

MDPI and ACS Style

Sova, M.; Genzor, S.; Kolek, V.; Čtvrtlík, F.; Asswad, A.G.; Zela, O.; Tauber, Z. Epicardial Fat in Patients with Chronic Obstructive Pulmonary Disease as a Marker of High Cardiovascular Risk. Adv. Respir. Med. 2018, 86, 314-318. https://doi.org/10.5603/ARM.a2018.0051

AMA Style

Sova M, Genzor S, Kolek V, Čtvrtlík F, Asswad AG, Zela O, Tauber Z. Epicardial Fat in Patients with Chronic Obstructive Pulmonary Disease as a Marker of High Cardiovascular Risk. Advances in Respiratory Medicine. 2018; 86(6):314-318. https://doi.org/10.5603/ARM.a2018.0051

Chicago/Turabian Style

Sova, Milan, Samuel Genzor, Vítězslav Kolek, Filip Čtvrtlík, Amjad Ghazal Asswad, Ondřej Zela, and Zdeněk Tauber. 2018. "Epicardial Fat in Patients with Chronic Obstructive Pulmonary Disease as a Marker of High Cardiovascular Risk" Advances in Respiratory Medicine 86, no. 6: 314-318. https://doi.org/10.5603/ARM.a2018.0051

Article Metrics

Back to TopTop